John Murad • USC Profiles (original) (raw)
- Current state of CAR-T cell therapies for solid tumors. Med. 2026 Feb 16; 101028. Rosa R, Liu J, Lu C, Abou-El-Enein M, Murad JP, Priceman SJ. PMID: 41702407.
View in: PubMed Mentions: Fields: - Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery. Nat Biomed Eng. 2025 Oct 01. Murad JP, Christian L, Rosa R, Ren Y, Buckley AJ, Lee EHJ, Lopez LS, Park AK, Yang J, Yamaguchi Y, Trac C, Adkins LN, Chang WC, Martinez C, June CH, Forman SJ, Ishihara J, Lee JK, Stern LA, Priceman SJ. PMID: 41034514.
View in: PubMed Mentions: 10 Fields:
Translation:HumansAnimalsCells - Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. J Immunother Cancer. 2025 Aug 11; 13(8). Park AK, Monroy I, Ren Y, Lu C, Chaurasiya S, Valencia H, Lent-Koop J, Cook C, Kang S, Lopez L, Murad JP, Yamaguchi Y, Urak R, Chang WC, Shah M, Chong LMO, Fong Y, Forman SJ, Wang X, Priceman SJ. PMID: 40789743; PMCID: PMC12352182.
View in: PubMed Mentions: 1 Fields:
Translation:HumansAnimalsCells - Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 delivery. bioRxiv. 2025 May 19. Murad JP, Christian L, Rosa R, Ren Y, Lee EHJ, Lopez LS, Park AK, Yang J, Trac C, Adkins LN, Chang WC, Martinez C, June CH, Forman SJ, Ishihara J, Lee JK, Stern LA, Priceman SJ. PMID: 40406466; PMCID: PMC12097497.
View in: PubMed Mentions: - PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med. 2024 Jun; 30(6):1636-1644. Dorff TB, Blanchard MS, Adkins LN, Luebbert L, Leggett N, Shishido SN, Macias A, Del Real MM, Dhapola G, Egelston C, Murad JP, Rosa R, Paul J, Chaudhry A, Martirosyan H, Gerdts E, Wagner JR, Stiller T, Tilakawardane D, Pal S, Martinez C, Reiter RE, Budde LE, D'Apuzzo M, Kuhn P, Pachter L, Forman SJ, Priceman SJ. PMID: 38867077; PMCID: PMC11186768.
View in: PubMed Mentions: 59 Fields:
Translation:HumansCellsCTClinical Trials - Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells. Mol Ther Oncol. 2024 Jun 20; 32(2):200789. Kennewick KT, Yamaguchi Y, Gibson J, Gerdts EA, Jeang B, Tilakawardane D, Murad JP, Chang WC, Wright SL, Thiel MS, Forman SJ, Stern LA, Priceman SJ. PMID: 38939825; PMCID: PMC11208731.
View in: PubMed Mentions: 2 - Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat Commun. 2023 08 07; 14(1):4737. Lee EHJ, Murad JP, Christian L, Gibson J, Yamaguchi Y, Cullen C, Gumber D, Park AK, Young C, Monroy I, Yang J, Stern LA, Adkins LN, Dhapola G, Gittins B, Chang WC, Martinez C, Woo Y, Cristea M, Rodriguez-Rodriguez L, Ishihara J, Lee JK, Forman SJ, Wang LD, Priceman SJ. PMID: 37550294; PMCID: PMC10406808.
View in: PubMed Mentions: 52 Fields:
Translation:HumansAnimalsCells - Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. bioRxiv. 2023 Jan 07. Jun Lee EH, Cullen C, Murad JP, Gumber D, Park AK, Yang J, Stern LA, Adkins LN, Dhapola G, Gittins B, Chung-Chang W, Martinez C, Woo Y, Cristea M, Rodriguez-Rodriguez L, Ishihara J, Lee JK, Forman SJ, Wang LD, Priceman SJ. PMID: 36711615; PMCID: PMC9881930.
View in: PubMed Mentions: - Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control. Nat Biomed Eng. 2021 11; 5(11):1348-1359. Miller IC, Zamat A, Sun LK, Phuengkham H, Harris AM, Gamboa L, Yang J, Murad JP, Priceman SJ, Kwong GA. PMID: 34385695; PMCID: PMC8791016.
View in: PubMed Mentions: 80 Fields:
Translation:AnimalsCells - Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol Ther. 2021 07 07; 29(7):2335-2349. Murad JP, Tilakawardane D, Park AK, Lopez LS, Young CA, Gibson J, Yamaguchi Y, Lee HJ, Kennewick KT, Gittins BJ, Chang WC, Tran CP, Martinez C, Wu AM, Reiter RE, Dorff TB, Forman SJ, Priceman SJ. PMID: 33647456; PMCID: PMC8261088.
View in: PubMed Mentions: 61 Fields:
Translation:HumansAnimalsCells - Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci Transl Med. 2020 09 02; 12(559). Park AK, Fong Y, Kim SI, Yang J, Murad JP, Lu J, Jeang B, Chang WC, Chen NG, Thomas SH, Forman SJ, Priceman SJ. PMID: 32878978; PMCID: PMC9126033.
View in: PubMed Mentions: 145 Fields:
Translation:AnimalsCells - Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells. Front Immunol. 2018; 9:2268. Murad JP, Kozlowska AK, Lee HJ, Ramamurthy M, Chang WC, Yazaki P, Colcher D, Shively J, Cristea M, Forman SJ, Priceman SJ. PMID: 30510550; PMCID: PMC6254427.
View in: PubMed Mentions: 83 Fields:
Translation:HumansAnimalsCells - Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain. Clin Cancer Res. 2018 01 01; 24(1):95-105. Priceman SJ, Tilakawardane D, Jeang B, Aguilar B, Murad JP, Park AK, Chang WC, Ostberg JR, Neman J, Jandial R, Portnow J, Forman SJ, Brown CE. PMID: 29061641; PMCID: PMC7685198.
View in: PubMed Mentions: 210 Fields:
Translation:HumansAnimalsCells - Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. Oncoimmunology. 2018; 7(2):e1380764. Priceman SJ, Gerdts EA, Tilakawardane D, Kennewick KT, Murad JP, Park AK, Jeang B, Yamaguchi Y, Yang X, Urak R, Weng L, Chang WC, Wright S, Pal S, Reiter RE, Wu AM, Brown CE, Forman SJ. PMID: 29308300; PMCID: PMC5749625.
View in: PubMed Mentions: 102 Fields: - Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. NPJ Breast Cancer. 2017; 3:6. Chung B, Esmaeili AA, Gopalakrishna-Pillai S, Murad JP, Andersen ES, Kumar Reddy N, Srinivasan G, Armstrong B, Chu C, Kim Y, Tong T, Waisman J, Yim JH, Badie B, Lee PP. PMID: 28649646; PMCID: PMC5460196.
View in: PubMed Mentions: 52 - Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis. Cell Rep. 2014 Aug 07; 8(3):871-882. Chung B, Stuge TB, Murad JP, Beilhack G, Andersen E, Armstrong BD, Weber JS, Lee PP. PMID: 25088413; PMCID: PMC4174572.
View in: PubMed Mentions: 17 Fields:
Translation:HumansCells - Current and experimental antibody-based therapeutics: insights, breakthroughs, setbacks and future directions. Curr Mol Med. 2013 Jan; 13(1):165-78. Murad JP, Lin OA, Espinosa EV, Khasawneh FT. PMID: 22834842.
View in: PubMed Mentions: 9 Fields:
Translation:Humans - A novel antibody targeting the ligand binding domain of the thromboxane A₂ receptor exhibits antithrombotic properties in vivo. Biochem Biophys Res Commun. 2012 May 11; 421(3):456-61. Murad JP, Espinosa EV, Ting HJ, McClure D, Khasawneh FT. PMID: 22503974.
View in: PubMed Mentions: 6 Fields:
Translation:AnimalsCells - Mouse transient receptor potential channel 6: role in hemostasis and thrombogenesis. Biochem Biophys Res Commun. 2012 Jan 13; 417(2):853-6. Paez Espinosa EV, Murad JP, Ting HJ, Khasawneh FT. PMID: 22206677.
View in: PubMed Mentions: 13 Fields:
Translation:AnimalsCells - Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan. J Cardiovasc Pharmacol Ther. 2012 Sep; 17(3):308-14. Murad JP, Espinosa EV, Ting HJ, Khasawneh FT. PMID: 22123197.
View in: PubMed Mentions: 7 Fields:
Translation:Animals - Aspirin: pharmacology and clinical applications. Thrombosis. 2012; 2012:173124. Paez Espinosa EV, Murad JP, Khasawneh FT. PMID: 22195279; PMCID: PMC3236360.
View in: PubMed Mentions: 31 - Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting. J Cardiovasc Pharmacol Ther. 2012 Sep; 17(3):248-59. Ting HJ, Murad JP, Espinosa EV, Khasawneh FT. PMID: 22064668.
View in: PubMed Mentions: 10 Fields:
Translation:HumansCells - The C-terminal segment of the second extracellular loop of the thromboxane A2 receptor plays an important role in platelet aggregation. Biochem Pharmacol. 2012 Jan 01; 83(1):88-96. Murad JP, Espinosa EV, Ting HJ, Khasawneh FT. PMID: 22008592.
View in: PubMed Mentions: 6 Fields:
Translation:HumansAnimalsCells
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs